These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2899458)

  • 1. Partial inhibition of the growth of transplanted dunning rat prostate tumors with the long-acting somatostatin analogue sandostatin (SMS 201-995).
    Siegel RA; Tolcsvai L; Rudin M
    Cancer Res; 1988 Aug; 48(16):4651-5. PubMed ID: 2899458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonist RC-3095 on the growth of the androgen-independent Dunning R-3327-AT-1 rat prostate cancer.
    Pinski J; Reile H; Halmos G; Groot K; Schally AV
    Cancer Res; 1994 Jan; 54(1):169-74. PubMed ID: 7903203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted cytotoxic analogue of somatostatin AN-238 inhibits growth of androgen-independent Dunning R-3327-AT-1 prostate cancer in rats at nontoxic doses.
    Koppan M; Nagy A; Schally AV; Arencibia JM; Plonowski A; Halmos G
    Cancer Res; 1998 Sep; 58(18):4132-7. PubMed ID: 9751625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of PC-3 human androgen-independent prostate cancer and its metastases by cytotoxic somatostatin analogue AN-238.
    Plonowski A; Schally AV; Nagy A; Sun B; Szepeshazi K
    Cancer Res; 1999 Apr; 59(8):1947-53. PubMed ID: 10213505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D inhibition of prostate adenocarcinoma growth and metastasis in the Dunning rat prostate model system.
    Getzenberg RH; Light BW; Lapco PE; Konety BR; Nangia AK; Acierno JS; Dhir R; Shurin Z; Day RS; Trump DL; Johnson CS
    Urology; 1997 Dec; 50(6):999-1006. PubMed ID: 9426741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial effects of androgen-primed chemotherapy in the Dunning R3327 G model of prostatic cancer.
    English HF; Heitjan DF; Lancaster S; Santen RJ
    Cancer Res; 1991 Apr; 51(7):1760-5. PubMed ID: 2004359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effect of somatostatin analogue RC-160 on the growth of hepatic metastases of colon cancer in rats: a study with magnetic resonance imaging.
    Qin Y; Van Cauteren M; Osteaux M; Schally AV; Willems G
    Cancer Res; 1992 Nov; 52(21):6025-30. PubMed ID: 1356623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained in vivo regression of Dunning H rat prostate cancers treated with combinations of androgen ablation and Trk tyrosine kinase inhibitors, CEP-751 (KT-6587) or CEP-701 (KT-5555).
    George DJ; Dionne CA; Jani J; Angeles T; Murakata C; Lamb J; Isaacs JT
    Cancer Res; 1999 May; 59(10):2395-401. PubMed ID: 10344749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of nucleoside analogue BCH-4556 on prostate cancer growth and metastases in vitro and in vivo.
    Rabbani SA; Harakidas P; Bowlin T; Attardo G
    Cancer Res; 1998 Aug; 58(15):3461-5. PubMed ID: 9699681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of prostate cancer metastasis in vivo: a comparison of 1,23-dihydroxyvitamin D (calcitriol) and EB1089.
    Lokeshwar BL; Schwartz GG; Selzer MG; Burnstein KL; Zhuang SH; Block NL; Binderup L
    Cancer Epidemiol Biomarkers Prev; 1999 Mar; 8(3):241-8. PubMed ID: 10090302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid suppression of plasma testosterone levels and tumor growth in the dunning rat model treated with degarelix, a new gonadotropin-releasing hormone antagonist.
    Princivalle M; Broqua P; White R; Meyer J; Mayer G; Elliott L; Bjarnason K; Haigh R; Yea C
    J Pharmacol Exp Ther; 2007 Mar; 320(3):1113-8. PubMed ID: 17179469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of somatostatin analogues in complete antiandrogen treatment in patients with prostatic carcinoma.
    Vainas G; Pasaitou V; Galaktidou G; Maris K; Christodoulou K; Constantinidis C; Kortsaris AH
    J Exp Clin Cancer Res; 1997 Mar; 16(1):119-26. PubMed ID: 9148872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lanthionine-somatostatin analogs: synthesis, characterization, biological activity, and enzymatic stability studies.
    Osapay G; Prokai L; Kim HS; Medzihradszky KF; Coy DH; Liapakis G; Reisine T; Melacini G; Zhu Q; Wang SH; Mattern RH; Goodman M
    J Med Chem; 1997 Jul; 40(14):2241-51. PubMed ID: 9216843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functionality of estrogen receptor and tamoxifen treatment of R3327 Dunning rat prostate adenocarcinoma.
    Ip MM; Milholland RJ; Rosen F
    Cancer Res; 1980 Jul; 40(7):2188-93. PubMed ID: 7388787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiproliferative and antimetastatic effects of gossypol on Dunning prostate cell-bearing Copenhagen rats.
    Chang CJ; Ghosh PK; Hu YF; Brueggemeier RW; Lin YC
    Res Commun Chem Pathol Pharmacol; 1993 Mar; 79(3):293-312. PubMed ID: 8480076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the preestrogen 4-androstene-3,17-dion-19-al on the Dunning R3327 prostatic adenocarcinoma.
    Marks TA; Petrow V
    Cancer Res; 1983 Aug; 43(8):3687-90. PubMed ID: 6861138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic fluid hyperthermia (MFH)reduces prostate cancer growth in the orthotopic Dunning R3327 rat model.
    Johannsen M; Thiesen B; Jordan A; Taymoorian K; Gneveckow U; Waldöfner N; Scholz R; Koch M; Lein M; Jung K; Loening SA
    Prostate; 2005 Aug; 64(3):283-92. PubMed ID: 15726645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of intermittent diethylstilbestrol diphosphate administration on the R3327 rat prostatic carcinoma.
    Russo P; Liguori G; Heston WD; Huryk R; Yang CR; Fair WR; Whitmore WF; Herr HW
    Cancer Res; 1987 Nov; 47(22):5967-70. PubMed ID: 3664500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor progression in serial passages of the Dunning R3327-G rat prostatic adenocarcinoma: growth rate response to endocrine manipulation.
    Pollack A; Block NL; Stover BJ; Irvin GL
    Cancer Res; 1985 Mar; 45(3):1052-7. PubMed ID: 3971360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Somatostatin analogues in treatment of gastrointestinal and pancreatic neuroendocrine tumors].
    Simonenko VB; Dulin PA; Makanin MA
    Klin Med (Mosk); 2006; 84(4):4-8. PubMed ID: 16755846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.